ClinicalTrials.Veeva

Menu

Outlook Quality of Life Intervention

VA Office of Research and Development logo

VA Office of Research and Development

Status

Completed

Conditions

Chronic Obstructive Pulmonary Disease
Cancer
Congestive Heart Failure

Treatments

Other: Attention Control
Other: Life completion and preparation

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT00784095
IAD 07-162

Details and patient eligibility

About

The purpose of this study is to determine whether discussions of life story, forgiveness, and future goals improve quality of life for patients with serious illness.

Full description

This is a pilot randomized control trial to evaluate the feasibility of the Outlook intervention. 36 veterans with advanced cancer, congestive heart failure (CHF) or chronic obstructive pulmonary disease (COPD) will be randomly assigned to one of three intervention groups and complete a brief battery of pre-test measures. Subjects in the first group ("treatment") will meet with a facilitator three times for a period of 45 min-1 hour. In the first session, subjects will be asked to discuss issues related to life review. In the second session, participants will be asked to speak in more depth about issues such as regret, forgiveness and things left undone, In the final session, subjects will focus on heritage and legacy. The subjects in the second group ("attention control") will meet with a facilitator three times for a period of 45 min- 1 hour and listen to a non-guided relaxation compact disk (CD). The third group of participants ("true control") will be exposed to no intervention or attention control. One week and two weeks later, participants in all groups will receive post-test measures administered by a blinded interviewer.

Enrollment

36 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients with advanced cancer, CHF or COPD.

Exclusion criteria

Cognitive impairment, inability to speak, non-English speaking

Trial design

36 participants in 3 patient groups

Preparation and Completion
Experimental group
Description:
Subjects in the first group ("treatment") met with the facilitator three times for a period of forty-five minutes to one hour to discuss issues of life completion and preparation. In the first session, subjects were asked to discuss issues related to life review. In session two, participants spoke about issues of regret and forgiveness. In the final session, subjects discussed issues of heritage and legacy.
Treatment:
Other: Life completion and preparation
Attention Control
Active Comparator group
Description:
The subjects in the second group ("attention control") met with a facilitator three times for 45 minutes and listened to a non-guided relaxation CD.
Treatment:
Other: Attention Control
True Control
No Intervention group
Description:
Subjects in the third group ("true control") were exposed to no intervention or attention control.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems